AR and colorectal carcinoma: These findings were validated in the TCGA CRC cohort (R = 0.46, P < 0.001 and R = 0.53, P < 0.001, respectively) (Fig. 2B, lower panel), supporting an association between the AR and M2-related signatures in CRC.